# MICAFUNGIN SODIUM
> **ANDA220296** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2026-03-17
## Drug
- **FDA Application Number:** ANDA220296
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MICAFUNGIN SODIUM
- **Generic name:** Micafungin Sodium
- **Active ingredients:** MICAFUNGIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **First approval:** 2026-03-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220296)
---
*MORVS · CC0 1.0*